107 related articles for article (PubMed ID: 9065796)
21. Expression of matrix metalloproteinase matrilysin (MMP-7) was induced by activated Ki-ras via AP-1 activation in SW1417 colon cancer cells.
Yamamoto H; Itoh F; Senota A; Adachi Y; Yoshimoto M; Endoh T; Hinoda Y; Yachi A; Imai K
J Clin Lab Anal; 1995; 9(5):297-301. PubMed ID: 8531010
[TBL] [Abstract][Full Text] [Related]
22. Translational augmentation of pro-matrix metalloproteinase 3 (prostromelysin 1) and a tissue inhibitor of metalloproteinases (TIMP)-1 mRNAs by epidermal growth factor and transforming growth factor alpha, but not by interleukin 1 alpha or 12-O-tetradecanoylphorbol 13-acetate in human uterine cervical fibroblasts: the possible involvement of an atypical protein kinase C.
Hosono T; Ito A; Sato T; Nagase H; Mori Y
Biol Pharm Bull; 1996 Oct; 19(10):1285-90. PubMed ID: 8913498
[TBL] [Abstract][Full Text] [Related]
23. Reversal of radiation resistance in LNCaP cells by targeting apoptosis through ceramide synthase.
Garzotto M; Haimovitz-Friedman A; Liao WC; White-Jones M; Huryk R; Heston WD; Cardon-Cardo C; Kolesnick R; Fuks Z
Cancer Res; 1999 Oct; 59(20):5194-201. PubMed ID: 10537297
[TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
25. Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma.
Salmela MT; Karjalainen-Lindsberg ML; Puolakkainen P; Saarialho-Kere U
Br J Cancer; 2001 Aug; 85(3):383-92. PubMed ID: 11487270
[TBL] [Abstract][Full Text] [Related]
26. Messenger ribonucleic acid levels of collagenase (MMP-13) and matrilysin (MMP-7) in virgin, pregnant, and postpartum uterus and cervix of rat.
Wolf K; Sandner P; Kurtz A; Moll W
Endocrinology; 1996 Dec; 137(12):5429-34. PubMed ID: 8940367
[TBL] [Abstract][Full Text] [Related]
27. Differential responsiveness of prostatic acid phosphatase and prostate-specific antigen mRNA to androgen in prostate cancer cells.
Lin MF; Lee MS; Garcia-Arenas R; Lin FF
Cell Biol Int; 2000; 24(10):681-9. PubMed ID: 11023645
[TBL] [Abstract][Full Text] [Related]
28. Matrilysin expression in human prostate carcinoma.
Knox JD; Wolf C; McDaniel K; Clark V; Loriot M; Bowden GT; Nagle RB
Mol Carcinog; 1996 Jan; 15(1):57-63. PubMed ID: 8561867
[TBL] [Abstract][Full Text] [Related]
29. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
Yamamoto H; Itoh F; Iku S; Adachi Y; Fukushima H; Sasaki S; Mukaiya M; Hirata K; Imai K
J Clin Oncol; 2001 Feb; 19(4):1118-27. PubMed ID: 11181677
[TBL] [Abstract][Full Text] [Related]
30. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
[TBL] [Abstract][Full Text] [Related]
31. Neutral endopeptidase promotes phorbol ester-induced apoptosis in prostate cancer cells by inhibiting neuropeptide-induced protein kinase C delta degradation.
Sumitomo M; Shen R; Goldberg JS; Dai J; Navarro D; Nanus DM
Cancer Res; 2000 Dec; 60(23):6590-6. PubMed ID: 11118039
[TBL] [Abstract][Full Text] [Related]
32. The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cells.
Chen MW; Vacherot F; De La Taille A; Gil-Diez-De-Medina S; Shen R; Friedman RA; Burchardt M; Chopin DK; Buttyan R
Oncogene; 2002 Nov; 21(51):7861-71. PubMed ID: 12420223
[TBL] [Abstract][Full Text] [Related]
33. The mitogen-activated protein kinase phosphatase vaccinia H1-related protein inhibits apoptosis in prostate cancer cells and is overexpressed in prostate cancer.
Arnoldussen YJ; Lorenzo PI; Pretorius ME; Waehre H; Risberg B; Maelandsmo GM; Danielsen HE; Saatcioglu F
Cancer Res; 2008 Nov; 68(22):9255-64. PubMed ID: 19010898
[TBL] [Abstract][Full Text] [Related]
34. Hormonal regulation of matrix metalloproteinase inhibitors in rat granulosa cells and ovaries.
Mann JS; Kindy MS; Edwards DR; Curry TE
Endocrinology; 1991 Apr; 128(4):1825-32. PubMed ID: 1848503
[TBL] [Abstract][Full Text] [Related]
35. Expressions of matrilysin and stromelysin in human glioma cells.
Nakano A; Tani E; Miyazaki K; Furuyama J; Matsumoto T
Biochem Biophys Res Commun; 1993 May; 192(3):999-1003. PubMed ID: 8507212
[TBL] [Abstract][Full Text] [Related]
36. Protein kinase C-alpha and -epsilon down-regulate cell surface sodium channels via differential mechanisms in adrenal chromaffin cells.
Yanagita T; Kobayashi H; Yamamoto R; Kataoka H; Yokoo H; Shiraishi S; Minami S; Koono M; Wada A
J Neurochem; 2000 Apr; 74(4):1674-84. PubMed ID: 10737626
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of non-genotoxic carcinogens and proliferating agents on cell growth, survival and apoptosis in hepatic cells in vitro.
Holmes TJ; Rainsford KD
Life Sci; 2001 Nov; 69(25-26):2975-92. PubMed ID: 11758825
[TBL] [Abstract][Full Text] [Related]
38. 12-o-Tetradecanoylphorbol 13-acetate prevents baicalein-induced apoptosis via activation of protein kinase C and JNKs in human leukemia cells.
Chow JM; Shen SC; Wu CY; Chen YC
Apoptosis; 2006 Nov; 11(11):1999-2011. PubMed ID: 17013757
[TBL] [Abstract][Full Text] [Related]
39. Matrix-degrading metalloproteinases in tumor progression.
Matrisian LM; Wright J; Newell K; Witty JP
Princess Takamatsu Symp; 1994; 24():152-61. PubMed ID: 8983072
[TBL] [Abstract][Full Text] [Related]
40. Matrilysin expression in the involuting rat ventral prostate.
Powell WC; Domann FE; Mitchen JM; Matrisian LM; Nagle RB; Bowden GT
Prostate; 1996 Sep; 29(3):159-68. PubMed ID: 8827084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
